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Abstract
Support Vector Machines (SVMs), and other supervised learning techniques have
been experimented for the bio-molecular diagnosis of malignancies, using also fea-
ture selection methods. The classification task is particularly difficult because of
the high dimensionality and low cardinality of gene expression data. In this paper
we investigate a different approach based on random subspace ensembles of SVMs:
a set of base learners is trained and aggregated using subsets of features randomly
drawn from the available DNA microarray data. Experimental results on the colon
adenocarcinoma diagnosis and medulloblastoma clinical outcome prediction show
the effectiveness of the proposed approach.
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1 Introduction
When the diagnosis of malignancies depend on multiple bio-molecular factors,
traditional clinical diagnostic approaches may sometimes fail [1] High through-
put bio-technologies based on large scale hybridization techniques (e.g. DNA
microarray) are able to produce information to support both diagnosis and
prognosis of malignancies at bio-molecular level, but the problem of extracting
significant knowledge from the data becomes critical because of the peculiar
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characteristics of gene expression data. In fact, DNA microarray data are usu-
ally characterized by a small number of vectors of high dimension that give
rise to the so called curse of dimensionality problem [2].
A possible approach to reduce the dimensionality consists in applying fea-
ture selection methods [3]. Considering that feature selection is a NP-hard
problem [4], we experiment with an alternative approach based on random
subspace ensembles [5], using linear SVMs as base learners. Indeed it has been
shown that linear SVMs are effective both as base learners in random sub-
space ensembles [6], and as classifiers for gene expression-based diagnosis of
cancer [7].
2 Random subspace ensembles for gene expression data analysis
Recently ensemble methods have been successfully applied to the bio-molecular
diagnosis of tumors [8,9].
In particular random subspace ensembles seem to be well-suited to the char-
acteristics of gene expression data, as they reduce the high dimensionality of
the data by randomly selecting subsets of genes, in presence of dependencies
among co-regulated genes [1]. Moreover, aggregating the resulting base clas-
sifiers trained on different subsets of gene expression levels, we may improve
diversity between base learners, without a substantial loss of accuracy due to
the redundancy of the available gene expression data.
At a high level, the random subspace ensemble method [5] is characterized by
three steps:
(1) Given a d-dimensional data set D = {(xj, tj)|1 ≤ j ≤ m}, xj ∈ X ⊂
Rd, tj ∈ C = {1, . . . , c}, n new projected k-dimensional data sets Di =
{(Pi(xj), tj)|1 ≤ j ≤ m} are generated (1 ≤ i ≤ n), where Pi is a random
projection Pi : Rd → Rk. Pi is obtained by random selecting, through
the uniform probability distribution, a k-subset A = {α1, . . . , αk} from
{1, 2, . . . , d} and setting Pi(x1, . . . , xd) = (xα1 , . . . , xαk).
(2) Each new data set Di is given in input to a fixed learning algorithm L
which outputs the classifiers hi for all i, 1 ≤ 1 ≤ n.
(3) The final classifier h is obtained by aggregating the base classifiers h1, ..., hn
through majority voting.
2
3 Experimental results
We have experimented with the method on 2 bio-medical problems, both based
on gene expression profiles of a relatively small group of patients: 1) Colon
adenocarcinoma bio-molecular diagnosis [10] 2) Medulloblastoma clinical out-
come prediction [11]. We extended the NEURObjects library [12], adding new
C++ classes and developing applications for random subspace ensembles.
3.1 Colon tumor prediction
The Colon adenocarcinoma data set is composed of 2000 genes and 62 samples:
40 colon tumor samples and 22 normal colon tissue samples. We used the same
preprocessing technique illustrated in [10].
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Fig. 1. SVM random subspace ensembles results on the colon data set (5-fold cross
validation). (a) Test and training error with respect to the dimension of the sub-
space (b) Sensitivity, specificity and precision with respect to the dimension of the
subspace.
Single linear SVMs trained using the entire set of gene expression data achieved
an error of 17.74 ± 10.87 % according to a 5-fold cross validation evaluation
of the generalization error. With random subspace ensembles of linear SVMs,
we obtained the minimum of the test error using 64-dimensional subspaces,
but also with 16 to 1024-dimensional subspaces results are equal or better
than single SVMs trained on the entire feature space (Fig 1 a). The ensembles
start to learn when 8 random genes are selected, and if we apply at least 16
gene-subspaces we achieve a reasonable specificity at the expense of a low
decrement of the sensitivity (Fig 1 b).
3
2 4 8 16 32 64 128 256 512 1024 2048
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
subspace dimension
e
rr
o
r
test error
training error
2 4 8 16 32 64 128 256 512 1024 2048
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Se
ns
itiv
ity
 −
 S
pe
cif
ici
ty
 −
 P
re
cis
io
n
sensitivity
specificity
precision
subspace dimension
(a) (b)
Fig. 2. SVM random subspace ensembles results on the medulloblastoma data set
(5-fold cross validation). (a) Test and training error with respect to the dimension of
the subspace (b) Sensitivity, specificity and precision with respect to the dimension
of the subspace.
3.2 Medulloblastoma clinical outcome prediction
The second problem concerns with the prediction of medulloblastoma clinical
outcome by gene expression profiling. The data set is composed of 60 samples,
with 39 survivors and 21 treatment failures. We selected about 4000 genes from
the original 7129, obtained by the same preprocessing techniques adopted in
the original work [11].
Single linear SVMs trained using the entire set of gene expression data achieved
an error of 28.33 ± 9.50 % according to a 5-fold cross validation estimate of
the generalization error.
Random subspace ensembles outperform single SVMs trained on the entire
set of the gene expression data. The minimum of the test error is registered
with 256-dimensional subspaces, but in this case we need from 128 to 512-
dimensional random subsets of genes to achieve better results than single
SVMs (Fig 2 a). In all cases we obtained low sensitivity (slightly better for
subspaces between 128 and 512 dimensions), and large specificity for a large
range of randomly selected genes (Fig 2 b). Moreover our ensemble approach
on medulloblastoma clinical outcome prediction achieves better accuracy and
sensitivity with respect to SVMs combined with feature selection methods
proposed in [11].
4
4 Conclusions
Random subspace ensembles outperform single SVMs on both the considered
classification tasks. The null hypothesis that the random subspace ensemble
has the same error rate as single SVMs is rejected at 0.05 significance level
according to the 5-fold cross validated paired t-test for both the Colon and
Medulloblastoma data sets.
Moreover we achieve better results with random subspace ensembles for a quite
large choice of the subspace dimension (Fig. 1 and 2). Only for subspaces of
very low dimension the quality of the resulting classifier is low.
The encouraging experimental results suggest to apply random subspace tech-
niques to high-dimensional bio-molecular diagnostic problems, possibly com-
bining the proposed ensemble approach with state-of-the-art feature selection
methods.
Acknowledgments
We would like to thank the C.I.L.E.A. for providing Avogadro (http://www.cilea.it),
the Linux cluster of Xeon double processors computers used in our experi-
ments.
References
[1] A. Alizadeh, et al., Towards a novel classification of human malignancies based
on gene expression, J. Pathol. 195 (2001) 41–52.
[2] R. Bellman, Adaptive Control Processes: a Guided Tour, Princeton University
Press, New Jersey, 1961.
[3] I. Guyon, J. Weston, S. Barnhill, V. Vapnik, Gene Selection for Cancer
Classification using Support Vector Machines, Machine Learning 46 (1/3)
(2002) 389–422.
[4] E. Amaldi, V. Kann, On the approximation of minimizing non zero variables or
unsatisfied relations in linear systems, Theoretical Computer Science 209 (1998)
237–260.
[5] T. Ho, The random subspace method for constructing decision forests, IEEE
Trans. on Pattern Analysis and Machine Intelligence 20 (8) (1998) 832–844.
5
[6] M. Skurichina, R. Duin, Bagging, boosting and the randon subspace method
for linear classifiers, Pattern Analysis and Applications 5 (2) (2002) 121–135.
[7] T. Furey, N. Cristianini, N. Duffy, D. Bednarski, M. Schummer, D. Haussler,
Support vector machine classification and validation of cancer tissue samples
using microarray expression data, Bioinformatics 16 (10) (2000) 906–914.
[8] S. Dudoit, J. Fridlyand, T. Speed, Comparison of discrimination methods for
the classification of tumors using gene expression data, Journal of American
Statistical Association 97 (457) (2002) 77–87.
[9] G. Valentini, M. Muselli, F. Ruffino, Cancer recognition with bagged ensembles
of Support Vector Machines, Neurocomputing 56 (2004) 461–466.
[10] U. Alon et al., Broad patterns of gene expressions revealed by clustering
analysis of tumor and normal colon tissues probed by oligonucleotide arrays,
Proceeedings of the National Academy of Sciences 96 (1999) 6745–6750.
[11] S. Pomeroy et al., Gene Expression-Based Classification and Outcome
Prediction of Central Nervous System Embryonal Tumors, Nature 415 (2002)
436–442.
[12] G. Valentini, F. Masulli, NEURObjects: an object-oriented library for neural
network development, Neurocomputing 48 (1–4) (2002) 623–646.
6
